S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Why This Bear Market Is Not Even Close to Being Done…
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Denmark says Nord Stream 1 natural gas pipeline has also stopped leaking
Denmark says Nord Stream 1 pipelines stop leaking
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Brazil holds historic election with Lula against Bolsonaro
US shift away from coal hits tribal community in New Mexico
New Battery Tech to “Eat Lithium’s Lunch”? (Ad)
Tesla sales bounce back in Q3 but fall short of estimates
Allies aim for risky Russian oil price cap as winter nears
NYSE:TDOC

Teladoc Health - TDOC Price Target & Analyst Ratings

$25.35
-0.88 (-3.35%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$25.33
$27.04
50-Day Range
$25.35
$43.24
52-Week Range
$25.33
$156.82
Volume
4.88 million shs
Average Volume
4.33 million shs
Market Capitalization
$4.09 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$61.03

Teladoc Health Consensus Rating and Price Target (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 29 Analyst Ratings

Consensus Analyst Price Target

$61.03
140.76% Upside
High Prediction$210.00
Average Prediction$61.03
Low Prediction$25.00
TypeCurrent
10/2/21 to 10/2/22
1 Month Ago
9/2/21 to 9/2/22
3 Months Ago
7/4/21 to 7/4/22
1 Year Ago
10/2/20 to 10/2/21
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
5 Buy rating(s)
8 Buy rating(s)
11 Buy rating(s)
Hold
24 Hold rating(s)
22 Hold rating(s)
18 Hold rating(s)
11 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$61.03$64.83$84.30$215.45
Predicted Upside140.76% Upside14.15% Upside20.11% Upside18.61% Upside
Get Teladoc Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.


TDOC Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TDOC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Teladoc Health Stock vs. The Competition

TypeTeladoc HealthMedical CompaniesS&P 500
Consensus Rating Score
2.10
2.68
2.49
Consensus RatingHoldBuyHold
Predicted Upside140.76% Upside1,098.70% Upside35.92% Upside
News Sentiment RatingNeutral News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
651
65.96%
Underperform Votes
336
34.04%
Avg. Outperform Votes
166
66.67%
Avg. Underperform Votes
83
33.33%
Avg. Outperform Votes
852
68.43%
Avg. Underperform Votes
393
31.57%

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
9/28/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$53.00 ➝ $35.00+31.43%
9/27/2022Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$34.00 ➝ $31.00+17.34%
9/15/2022KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSector Weight ➝ Sector Weight
9/7/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageHold$35.00+20.56%
8/17/2022Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Sell$25.00-36.63%
8/12/2022DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$45.00+18.45%
8/2/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$58.00 ➝ $34.00-7.63%
8/2/2022Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$42.00 ➝ $35.00-4.92%
8/2/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform$58.00 ➝ $34.00-7.63%
7/28/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Davis
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetMarket Perform$35.00 ➝ $34.00+1.46%
7/28/2022Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$50.00 ➝ $45.00+31.85%
7/28/2022Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$36.00 ➝ $30.00-30.62%
7/28/2022Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
7/28/2022The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral$55.00 ➝ $36.00-16.74%
7/28/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$43.00 ➝ $38.00-12.12%
7/28/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$65.00 ➝ $55.00+27.20%
7/28/2022Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOverweight$42.00 ➝ $40.00-7.49%
7/20/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$45.00 ➝ $42.00+2.07%
7/6/2022Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$36.00 ➝ $42.00+8.22%
5/5/2022Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Eade
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
4/28/2022JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral
4/28/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$67.00 ➝ $30.00-5.93%
4/28/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral$114.00 ➝ $35.00-37.49%
4/28/2022Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Equal Weight$104.00 ➝ $40.00-28.56%
4/28/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
4/27/2022Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$72.00 ➝ $64.00+10.78%
3/8/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$130.00 ➝ $72.00+13.03%
2/23/2022Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetInline$90.00 ➝ $70.00+8.86%
2/7/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetHold$113.00 ➝ $82.00+9.99%
11/22/2021BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
11/19/2021Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$140.00 ➝ $135.00+8.87%
10/28/2021Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral$185.00 ➝ $150.00+8.20%
5/13/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sandy Draper
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetHold$144.00 ➝ $200.00+5.10%
4/30/2020CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetNeutral$152.00 ➝ $165.00+0.33%
(Data available from 10/2/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












TDOC Price Target - Frequently Asked Questions

What is Teladoc Health's consensus rating and price target?

According to the issued ratings of 29 analysts in the last year, the consensus rating for Teladoc Health stock is Hold based on the current 1 sell rating, 24 hold ratings and 4 buy ratings for TDOC. The average twelve-month price prediction for Teladoc Health is $61.03 with a high price target of $210.00 and a low price target of $25.00. Learn more on TDOC's analyst rating history.

Do Wall Street analysts like Teladoc Health more than its competitors?

Analysts like Teladoc Health less than other Medical companies. The consensus rating for Teladoc Health is Hold while the average consensus rating for medical companies is Buy. Learn more on how TDOC compares to other companies.

Do MarketBeat users like Teladoc Health more than its competitors?

MarketBeat users like Teladoc Health less than other Medical companies. 65.96% of MarketBeat users gave Teladoc Health an outperform vote while medical companies recieve an average of 66.53% outperform votes by MarketBeat users.

Is Teladoc Health being downgraded by Wall Street analysts?

Over the previous 90 days, Teladoc Health's stock had 6 downgrades by analysts.

Does Teladoc Health's stock price have much upside?

According to analysts, Teladoc Health's stock has a predicted upside of 12.89% based on their 12-month price targets.


Stock Ratings Reports and Tools

This page (NYSE:TDOC) was last updated on 10/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.